Progress Towards an OECD Reporting Framework for Transcriptomics and Metabolomics in Regulatory Toxicology - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue Regulatory Toxicology and Pharmacology Année : 2021

Progress Towards an OECD Reporting Framework for Transcriptomics and Metabolomics in Regulatory Toxicology

Laurent Debrauwer
Frank Faulhammer
  • Fonction : Auteur
Gina Hilton
  • Fonction : Auteur
Aniko Kende
  • Fonction : Auteur
Thomas Lawson
  • Fonction : Auteur
Oliver Schmitz
  • Fonction : Auteur
Tomasz Sobanski
  • Fonction : Auteur
Volker Strauss
  • Fonction : Auteur
Monica Vaccari
  • Fonction : Auteur
Antony Williams
Andrew Williams

Résumé

Omics methodologies are widely used in toxicological research to understand modes and mechanisms of toxicity. Increasingly, these methodologies are being applied to questions of regulatory interest such as molecular point-of-departure derivation and chemical grouping/read-across. Despite its value, widespread regulatory acceptance of omics data has not yet occurred. Barriers to the routine application of omics data in regulatory decision making have been: 1) lack of transparency for data processing methods used to convert raw data into an interpretable list of observations; and 2) lack of standardization in reporting to ensure that omics data, associated metadata and the methodologies used to generate results are available for review by stakeholders, including regulators. Thus, in 2017, the Organisation for Economic Co-operation and Development (OECD) Extended Advisory Group on Molecular Screening and Toxicogenomics (EAGMST) launched a project to develop guidance for the reporting of omics data aimed at fostering further regulatory use. Here, we report on the ongoing development of the first formal reporting framework describing the processing and analysis of both transcriptomic and metabolomic data for regulatory toxicology. We introduce the modular structure, content, harmonization and strategy for trialling this reporting framework prior to its publication by the OECD.
Fichier principal
Vignette du fichier
main.pdf (597.02 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03313213 , version 1 (25-01-2024)

Identifiants

Citer

Joshua Harrill, Mark Viant, Carole Yauk, Magdalini Sachana, Timothy Gant, et al.. Progress Towards an OECD Reporting Framework for Transcriptomics and Metabolomics in Regulatory Toxicology. Regulatory Toxicology and Pharmacology, 2021, ⟨10.1016/j.yrtph.2021.105020⟩. ⟨hal-03313213⟩
57 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More